The Patented Medicine Prices Review Board (PMPRB) requires access to Canadian private drug plan data in order to complete its analytical priorities and fulfill its reporting mandate. Some of the analytical priorities that require this data include Private Drug Plans in Canada and the Market Intelligence Reports.
The buyer plans to award this contract to a named supplier without competition. If your business can do this work, send a statement of capabilities to the contracting authority before March 5, 2021. If it qualifies, the buyer must open a full competition.
Get a plain-English breakdown of this tender — what they need, who can bid, how to approach it, and tips for small suppliers. Takes a couple of seconds.
1 past awards in this classification and 0 likely incumbents from this buyer. Pro shows who won and for how much.
Upgrade to Pro